Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin36.9%+0.4pp36.5%+2.2pp34.3%-1.2pp35.5%-1.3pp
Operating margin13.1%+4.1pp8.9%+0.4pp8.5%
Net margin2.4%+6.6pp-4.2%-0.7pp-3.5%+8.0pp-11.5%
Returns
Return on invested capital15.7%+5.2pp10.5%+3.1pp7.5%+13.7pp-6.2%-11.5pp
Efficiency
Asset turnover0.8×0.0×0.8×+0.1×0.7×+0.1×0.6×0.0×
Liquidity
Current ratio2.2×+0.8×1.4×-0.2×1.6×-0.2×1.9×-0.4×
Per Share
Book value per share-$0.22+38.3%-$0.35-415%$0.11-94.3%$1.98-16.7%
Valuation
Market capitalization$3.96B+61.4%$2.45B+31.9%$1.86B+517%$301.44M-57.9%
Price / earnings55×
Price / sales1.3×+0.4×0.9×+0.1×0.8×+0.6×0.1×-0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amneal Pharmaceuticals, Inc.'s profit margins?
Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.